secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2026-08-03T13:00:14+00:00
Accession:  0001079973-26-000997
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Oncology Institute rebrands as Starling Oncology; ticker changes to STLN
----------------------------------------------------------------------------

- Company name changed to Starling Oncology, Inc. effective July 28, 2026.
- Common stock ticker symbol changes from TOI to STLN effective August 4, 2026.
- No stockholder approval required; CUSIP number remains 68236X100.
- CEO Dan Virnich says rebrand reflects scale and coordinated care model.
- Patient care unaffected; same phone numbers and portal access maintained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000107997326000997/0001079973-26-000997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000107997326000997/toi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-26-000997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer